Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial

BMC Medical Research Methodology

Volumn 10, Issue , 2010, Pages

  Woods, Beth S ^a   Hawkins, Neil ^a,b   Scott, David A ^a  

^a ICON PLC   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; META ANALYSIS; METHODOLOGY; MORTALITY; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

HUMANS; META-ANALYSIS AS TOPIC; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATISTICS AS TOPIC;

EID: 77953235448     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-10-54     Document Type: Article

References (31)

1. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. DM Caldwell AE Ades JPT Higgins, BMJ 2005 331 897 900 10.1136/bmj.331.7521.897 16223826
2. A chain of evidence with mixed comparisons: model for multi-parameter synthesis and consistency of evidence. AE Ades, Stat Med 2003 22 19 2995 3016 10.1002/sim.1566 12973783
3. Meta-analysis of multitreatment studies. V Hasselblad, Med Decis Making 1998 18 37 43 10.1177/0272989X9801800110 9456207
4. Modelling survival data in medical research. D Collett, Second 2003 Chapman & Hall/CRC
5. Survival analysis: a self-learning text. DG Kleinbaum M Klein, Springer, U.S Second 2005
6. Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis. A Ades M Sculpher AJ Sutton NJ Cooper KR Abrams N Welton G Lu, Pharmacoeconomics 2006 24 1 19 10.2165/00019053-200624010-00001 16445299
7. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. AW Chan A Hrábjartsson MT Haahr PC Gøtzsche DG Altman, JAMA 2004 291 20 2457 65 10.1001/jama.291.20.2457 15161896
8. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. MKB Parmar V Torri L Stewart, Stat Med 1998 17 2815 34 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0. CO;2-8 9921604
9. Meta-Analysis of Controlled Clinical Trials. A Whitehead, John Wiley and Sons: Chichester 2002
10. Evaluation of networks of randomised trials. G Salanti JP Higgins AE Ades JP Ioannidis, Stat Methods Med Res 2008 17 3 279 301 10.1177/0962280207080643 17925316
11. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. WL Baker EL Baker C Coleman, Pharmacotherapy 2009 29 8 891 905 10.1592/phco.29.8.891 19637942
12. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). G Boyd AH Morice JC Pounsford M Siebert N Peslis C Crawford, Eur Respir J 1997 10 815 21 9150318
13. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. P Calverley R Pauwels J Vestbo P Jones N Pride A Gulsvik J Anderson C Maden Trial of Inhaled Steroids and Long-Acting 2-Agonists (TRISTAN) Study Group, Lancet 2003 361 449 56 10.1016/S0140-6736(03)12459-2 12583942
14. Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the breathlessness, cough, and sputum scale (BCSS). B Celli D Halpin R Hepburn N Byrne ET Keating M Goldman, Resp Med 2003 97 suppl A 35 43
15. Randomised, double-blind, placebo-controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. PS Burge PMA Calverley S Spencer JA Anderson TK Maslen on behalf of the ISOLDE Study Investigators, BMJ 2000 320 1297 303 10.1136/bmj.320.7245.1297 10807619
16. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. PMA Calverley JA Anderson B Celli GT Ferguson C Jenkins PW Jones JC Yates J Vestbo for the TORCH Investigators, N Engl J Med 2007 356 775 89 10.1056/NEJMoa063070 17314337 (Pubitemid 46294610)
17. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. DD Sin L Wu JA Anderson, Thorax 2005 60 992 7 10.1136/thx.2005.045385 16227327
18. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. DJ Lunn A Thomas N Best D Spiegelhalter, Stat Comput 2000 10 325 337 10.1023/A:1008929526011
19. Bayesian measures of model complexity and fit (with discussion). DJ Spiegelhalter NJ Best BP Carlin A Van der Linde, J R Stat Soc 2002 64 1 34 10.1111/1467-9868.00353
20. DIC: Deviance Information Criterion. The BUGS project, http://www.mrc-bsu.cam.ac.uk/bugs/winbugs/dicpage.shtml#q9 Accessed 10/02/2010
21. Mixed treatment comparisons: outcome measures. Lecture notes from Indirect and Multiple Comparisons course. NJ Welton, Leicester University 2008
22. Mixed treatment comparison with multiple outcomes reported inconsistently across trials: Evaluation of antivirals for treatment of influenza A and B. NJ Welton NJ Cooper AE Ades G Lu AJ Sutton, Stat Med 2008 27 5620 39 10.1002/sim.3377 18680174
23. Performing meta-analysis with incomplete statistical information in clinical trials. J Ma W Liu A Hunter W Zhang, BMC Med Res Methodol 2008 8 1 56 10.1186/1471-2288-8-56 18706124
24. Meta-analysis when only the median survival times are known: a comparison with individual patient data results. S Michiels P Piedbois S Burdett N Syz L Stewart JP Pignon, Int J Technol Assess 2005 21 1 119 25
25. Practical methods for incorporating summary time-to-event data into meta-analysis. JF Tierney LA Stewart D Ghersi S Burdett MR Sydes, Trials 2007 8 16 10.1186/1745-6215-8-16 17555582
26. Aggregate data meta-analysis with time-to-event outcomes. PR Williamson C Tudur Smith JL Hutton AG Marson, Stat Med 2002 21 3337 51 10.1002/sim.1303 12407676
27. Chapter 7: Selecting studies and collecting data. JPT Higgins JJ Deeks (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, Higgins JPT, Green S, 2008 http://www.cochrane-handbook.org
28. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. JA Green JM Kirwan JF Tierney P Symonds L Fresco M Collingwood CJ Williams, Lancet 2001 358 8 781 86 10.1016/S0140-6736(01)05965-7 11564482
29. The Additional Value of Chemotherapy to Radiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Meta-Analysis of the Published Literature. JA Langendijk CR Leemans J Buter J Berkhof BJ Slotman, J Clin Oncol 2004 22 22 4604 12 10.1200/JCO.2004.10.074 15542811
30. The strengths and limitations of meta-analyses based on aggregate data. GH Lyman NM Kuderer, BMC Med Res Methodol 2005 5 1 14 10.1186/1471-2288-5-14 15850485
31. Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. RD Riley MC Simmonds MP Look, J Clin Epidemiol 2007 60 5 431 9 10.1016/j.jclinepi.2006. 09.009 17419953